Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid With Vitamin E in Nonalcoholic Steatohepatitis
Top Cited Papers
- 1 December 2006
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 4 (12) , 1537-1543
- https://doi.org/10.1016/j.cgh.2006.09.025
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effect of changes on body weight and lifestyle in nonalcoholic fatty liver diseaseJournal of Hepatology, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡Hepatology, 2004
- Cytokines and Nash: A Pilot Study of the Effects of Lifestyle Modification and Vitamin EHepatology, 2003
- The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agentExpert Opinion on Investigational Drugs, 2001
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999
- Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying DiseaseHepatology, 1999
- Comparison of serum concentrations of α-tocopherol and β-carotene in a cross-sectional sample of obese and nonobese children (NHANES III)The Journal of Pediatrics, 1999
- A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.Journal of Clinical Investigation, 1998
- Ursodeoxycholic Acid or Clofibrate in the Treatment of Non–Alcohol–Induced Steatohepatitis: A Pilot StudyHepatology, 1996